Litcius/Paper detail

Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies

Tycho Heimbach, Filippos Kesisoglou, Jasmina Novaković, Christophe Tistaert, Martin Mueller‐Zsigmondy, Sivacharan Kollipara, Tausif Ahmed, Amitava Mitra, Sandra Suarez‐Sharp

2021Journal of Pharmaceutical Sciences60 citationsDOI

Topics & Concepts

BioequivalenceIVIVCBiopharmaceuticsBiopharmaceutics Classification SystemContext (archaeology)Biochemical engineeringComputer sciencePharmacologyRisk analysis (engineering)Dissolution testingDrugMedicinePharmacokineticsChemistryEngineeringBiologyIn vitroPaleontologyPharmacognosyBiological activityBiochemistryDrug Solubulity and Delivery SystemsProtein purification and stabilityCrystallization and Solubility Studies
Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies | Litcius